India, Aug. 23 -- The shares of this company are vertically integrated, research and development-focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas are in the spotlight after it raised its stake in South African firm Adcock Ingram to 49%.

whatsapp With a market capitalisation of Rs. 15,829 cr, the shares of Natco Pharma Ltd closed at Rs. 883.80 per share, up from its previous close of Rs. 877.75 per share.

Strengthening Presence in South Africa The holding of NATCO Pharma in the South African pharmaceutical firm Adcock Ingram Holdings was increased from 35.75% to 49%, after purchasing an additional stake of 13.25% for about Rs. 1,060 crore. The company believe...